Gregory Scott Duncan
CIK 1831127 · CHIEF EXECUTIVE OFFICER · last filed 2026-03-06
Gregory Scott Duncan is a CHIEF EXECUTIVE OFFICER who has filed 25 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for DWTX, was dated Mar 6, 2026. Across all open-market trades the lifetime net is +$288.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $601.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$601.2K
3
25
$288.7K
Holdings By Company
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-06 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2026-01-27 | CRMD | Grant (A) | +30,453 | $0 | EDGAR |
| 2025-12-05 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-09-18 | CRMD | Exer (M) | +13,333 | $110.9K | EDGAR |
| 2025-07-01 | DWTX | Grant (A) | — | $0 | EDGAR |
| 2025-01-22 | CRMD | Grant (A) | +25,000 | $0 | EDGAR |
| 2024-03-20 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-18 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Buy (P) | +25,000 | $31.2K | EDGAR |
| 2023-02-15 | Dogwood Therapeutics, Inc. (VIRI) Delisted | Grant (A) | — | $0 | EDGAR |